26
26
60
60
4
4
13
13
13
13
3
3
4
4
5
5
4
4
2
2
2007
1997
University (215)Company (1)Investor (1)
1 - 10 of 253
Sort by
Research Grant
Project Number5R01AT005824-05Funding AgencyNational Institutes of HealthEffective Date2014-04-01Expiration Date2017-03-31Funding Amount$406,927
DESCRIPTION (provided by applicant): Conventional therapies for HIV infection have made great progress, but they remain complex, expensive and have many side effects. Many Complementary and Alternative Medicine (CAM) therapies are being used by patients with HIV infection, but which of them (if any) are in fact beneficial is still unclear, and whether their use makes economic sense is even less clear. The optimal method of determining appropriate treatments is the randomized control trial (RC…
Research Grant
Project Number5R01AT005824-04Funding AgencyNational Institutes of HealthEffective Date2013-04-01Expiration Date2014-03-31Funding Amount$366,234
DESCRIPTION (provided by applicant): Conventional therapies for HIV infection have made great progress, but they remain complex, expensive and have many side effects. Many Complementary and Alternative Medicine (CAM) therapies are being used by patients with HIV infection, but which of them (if any) are in fact beneficial is still unclear, and whether their use makes economic sense is even less clear. The optimal method of determining appropriate treatments is the randomized control trial (RC…
Research Grant
Project Number5R01AT005824-03Funding AgencyNational Institutes of HealthEffective Date2012-04-01Expiration Date2013-03-31Funding Amount$377,561
DESCRIPTION (provided by applicant): Conventional therapies for HIV infection have made great progress, but they remain complex, expensive and have many side effects. Many Complementary and Alternative Medicine (CAM) therapies are being used by patients with HIV infection, but which of them (if any) are in fact beneficial is still unclear, and whether their use makes economic sense is even less clear. The optimal method of determining appropriate treatments is the randomized control trial (RC…
Research Grant
Project Number5R01AT005824-02Funding AgencyNational Institutes of HealthEffective Date2011-04-01Expiration Date2012-03-31Funding Amount$377,561
DESCRIPTION (provided by applicant): Conventional therapies for HIV infection have made great progress, but they remain complex, expensive and have many side effects. Many Complementary and Alternative Medicine (CAM) therapies are being used by patients with HIV infection, but which of them (if any) are in fact beneficial is still unclear, and whether their use makes economic sense is even less clear. The optimal method of determining appropriate treatments is the randomized control trial (RC…
Research Grant
Project Number1R01AT005824-01Funding AgencyNational Institutes of HealthEffective Date2010-04-01Expiration Date2011-03-31Funding Amount$380,541
DESCRIPTION (provided by applicant): Conventional therapies for HIV infection have made great progress, but they remain complex, expensive and have many side effects. Many Complementary and Alternative Medicine (CAM) therapies are being used by patients with HIV infection, but which of them (if any) are in fact beneficial is still unclear, and whether their use makes economic sense is even less clear. The optimal method of determining appropriate treatments is the randomized control trial (RC…
Research Grant
Project Number5M01RR000071-46Funding AgencyNational Institutes of HealthEffective Date2009-03-01Expiration Date2009-07-31Funding Amount$1,224
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Carcinoma of the lung is the leading cause of cancer related deaths in North America. Non-small Cell Lung Cancer (NSCLC…
Research Grant
Project Number5M01RR000071-44Funding AgencyNational Institutes of HealthEffective Date2007-03-01Expiration Date2008-02-29Funding Amount$73,827
Research Grant
Project Number5M01RR000071-44Funding AgencyNational Institutes of HealthEffective Date2007-03-01Expiration Date2008-02-29Funding Amount$55,371
Research Grant
Project Number5R01AT000966-03Funding AgencyNational Institutes of HealthEffective Date2006-08-01Expiration Date2008-07-31Funding Amount$206,896
DESCRIPTION (provided by applicant): The broad long-term objective of this study is to develop non-toxic anticancer and immune-enhancing dietary supplements for the treatment of cancer and immune-deficiency diseases. The specific objective is to test whether a specific mixture of "Selected Vegetables and Herbs Mix (SV)", which consists of non-toxic botanicals containing known anti-cancer and/or immune enhancing components, may prolong the survival of stage 111B/IV non-small cell lung cancer (…
Research Grant
Project Number2M01RR000071-43Funding AgencyNational Institutes of HealthEffective Date2006-04-17Expiration Date2007-02-28Funding Amount$6,326
We found 253 documents that match your Search
Research Grants: 252
Clinical Trials: 1

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in